Two novel compounds（4a and 4b） were obtained by the association of 2,2,4-trimethyl-3-hydroxy-5-cyclohexenecarboxylate with （S） -isoserine derivatives. The space location of the hydroxyl group of compound 1 was ide...Two novel compounds（4a and 4b） were obtained by the association of 2,2,4-trimethyl-3-hydroxy-5-cyclohexenecarboxylate with （S） -isoserine derivatives. The space location of the hydroxyl group of compound 1 was identified via the formation of lactone 6. Fe2 （SO4）3·xH2O was used as the catalyst for the synthesis of lactone 6. The carboxyl group was selectively protected with diazomethane. All the products were characterized via ^1H NMR and mass spectra. The Docking study showed that the associations have the potential therapeutic use of DPP-Ⅳ inhibitor.展开更多
In this work,the removal of 2,4,6-tribromophenol(TBP)by ferric ion-activated sulfite[Fe(Ⅲ)/S(Ⅳ)]process was systematically investigated with determining the intermediate products and evaluating the influences of som...In this work,the removal of 2,4,6-tribromophenol(TBP)by ferric ion-activated sulfite[Fe(Ⅲ)/S(Ⅳ)]process was systematically investigated with determining the intermediate products and evaluating the influences of some operational conditions and water matrices.Our results show that batching addition of S(Ⅳ)benefits the S(Ⅳ)utilization efficiency and TBP removal,with SO_(4)^(-)being the primary reactive radical accounting for TBA degradation.The maximum TBP removal in the Fe(Ⅲ)/S(Ⅳ)process was observed at pH 4.0 and oxygen is essential in this process.With increasing Fe(Ⅲ)and S(Ⅳ)dosages from 0.05 and 0.1 mmol/L to 0.2 and 2.0 mmol/L,respectively,TBP removal followed trends of first increase then decrease.As the acute toxicity of the TBP solution was significantly reduced,the Fe(Ⅲ)/S(Ⅳ)process was believed to be a good choice in the treatment of TBP.展开更多
基金Supported by the National Natural Science Foundation of China(No. 20172019)
文摘Two novel compounds（4a and 4b） were obtained by the association of 2,2,4-trimethyl-3-hydroxy-5-cyclohexenecarboxylate with （S） -isoserine derivatives. The space location of the hydroxyl group of compound 1 was identified via the formation of lactone 6. Fe2 （SO4）3·xH2O was used as the catalyst for the synthesis of lactone 6. The carboxyl group was selectively protected with diazomethane. All the products were characterized via ^1H NMR and mass spectra. The Docking study showed that the associations have the potential therapeutic use of DPP-Ⅳ inhibitor.
基金The support by the National Natural Science Foundation of China(No.51878308)the Young Top-notch Talent Cultivation Program of Hubei Province。
文摘In this work,the removal of 2,4,6-tribromophenol(TBP)by ferric ion-activated sulfite[Fe(Ⅲ)/S(Ⅳ)]process was systematically investigated with determining the intermediate products and evaluating the influences of some operational conditions and water matrices.Our results show that batching addition of S(Ⅳ)benefits the S(Ⅳ)utilization efficiency and TBP removal,with SO_(4)^(-)being the primary reactive radical accounting for TBA degradation.The maximum TBP removal in the Fe(Ⅲ)/S(Ⅳ)process was observed at pH 4.0 and oxygen is essential in this process.With increasing Fe(Ⅲ)and S(Ⅳ)dosages from 0.05 and 0.1 mmol/L to 0.2 and 2.0 mmol/L,respectively,TBP removal followed trends of first increase then decrease.As the acute toxicity of the TBP solution was significantly reduced,the Fe(Ⅲ)/S(Ⅳ)process was believed to be a good choice in the treatment of TBP.
